Dabigatran Loading in Atrial Fibrillation

Introduction to Dabigatran Dosing

For patients with atrial fibrillation, the European Society of Cardiology recommends starting dabigatran at the standard therapeutic dose based on renal function and other patient factors, without a loading dose 1, 2

The European Heart Society recommends a dose reduction to 110 mg twice daily for patients aged ≥80 years or those receiving concomitant verapamil 2, 3
Individual dose reduction (to 110 mg twice daily) should be considered for patients aged 75-80 years, with moderate renal impairment, gastritis, esophagitis, or gastroesophageal reflux, or at increased risk of bleeding 2

The European Society of Cardiology recommends DOACs, including dabigatran, in preference to vitamin K antagonists like warfarin for stroke prevention in atrial fibrillation, except in patients with mechanical heart valves or moderate-to-severe mitral stenosis 1, 2
Anticoagulation is recommended for patients with a CHA₂DS₂-VA score ≥ 2 4

Dabigatran demonstrated a 34% reduction in stroke or systemic embolism compared to warfarin (HR 0.66, 95% CI 0.53-0.82) 5
Dabigatran showed a 74% reduction in hemorrhagic stroke compared to warfarin (HR 0.26, 95% CI 0.14-0.49) 5

Full standard doses of DOACs should be used unless specific dose-reduction criteria are met, to prevent underdosing and avoidable thromboembolic events 2
There is an increased risk of gastrointestinal bleeding with dabigatran 150 mg twice daily compared to warfarin (HR 1.50, 95% CI 1.19-1.89) 5

For patients transitioning from warfarin to dabigatran, switching is recommended if patients have failed to maintain adequate time in therapeutic range (TTR <70%) 2
For patients undergoing cardioversion, dabigatran should be administered for at least 3 weeks prior to the procedure if AF duration is >48 hours, or a transesophageal echocardiogram should be performed to rule out left atrial thrombi 3
After cardioversion, continuous oral anticoagulation is mandatory for at least 4 weeks, irrespective of CHA₂DS₂-VASc score 3